Mi-ot, Laiza .

HRN: 22-66-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
CO-AMOXICLAV 625MG (TAB)
01/18/2023
01/25/2023
PO
625 Mg Tab
BID
S/P NSVD With RMLE And Repair, UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: